INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,525 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
PR
Putnam Leah RChief Accounting Officer
BBBYBED BATH & BEYOND, INC.
Option exercise
M$5.81
5,811 sh
Feb 4, 2026Feb 6, 2026
Page 1362 of 1814
← PrevNext →
traded Feb 4, 2026
+2d
SEC Form 4

Evidence

17
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Grant or award
A—
68.8K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
LC
Lee CindyChief Financial Officer
VIRTVirtu Financial, Inc.
Tax withholding
F—
6,274 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
TS
Trivedi SurekhaSVP, Strategy & Sustainability
VLTOVeralto Corp
Grant or award
A—
537 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

17
HL
Hawes Jennifer LSVP - Chief HR Officer
ALLEAllegion plc
Grant or award
A—
2,777 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
PL
Pareja LeonardoCEO of eXp Realty
EXPIAGNT, Inc.
Option exercise
M—
9,372 sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

17
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
161.7K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

17
SM
Schroeder MarcPRESIDENT, INTERNATIONAL
LWLamb Weston Holdings, Inc.
Grant or award
A—
13.7K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

16
HL
Hawes Jennifer LSVP - Chief HR Officer
ALLEAllegion plc
Tax withholding
F$142K
830 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
LH
Lamb William HDirector
TBBKBancorp, Inc.
Gift
G—
1,200 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
IS
Ilardi David S.SVP - Allegion Americas
ALLEAllegion plc
Tax withholding
F$208K
1,212 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
LH
Lamb William HDirector
TBBKBancorp, Inc.
Gift
G—
1,200 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
SC
Sawyer Dorothy CVP
TROWPRICE T ROWE GROUP INC
Gift
G—
5,155 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

16
MT
McLain William Thomas Jr.EVP, CFO
EMNEASTMAN CHEMICAL CO
Option exercise
M$196K
3,013 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
MT
McLain William Thomas Jr.EVP, CFO
EMNEASTMAN CHEMICAL CO
Tax withholding
F$207K
2,636 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
MC
Martens Robert C.SVP-Chief Innovation & Design
ALLEAllegion plc
Tax withholding
F$155K
907 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
MJ
Mills Desmond JSVP & Chief Accounting Officer
WFRDWeatherford International plc
Tax withholding
F$247K
2,470 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

16
OJ
Olenik John JVP-Research & Engineering
PLPCPREFORMED LINE PRODUCTS CO
Tax withholding
F$242K
987 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

15
CM
Conner Penelope MDirector
ESEESCO TECHNOLOGIES INC
Option exercise
M$322K
1,349 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

15
BK
Balthaser KevinChief Financial Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
99.1K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
KW
Kolbeck Roland WilhelmChief Scientific Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
95.7K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
KW
Kolbeck Roland WilhelmChief Scientific Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
334.9K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
OL
Oliver Robin LeighDirector, President, COO
BAFNBayFirst Financial Corp.
Tax withholding
F$891
134 sh
Feb 3, 2026Feb 6, 2026
traded Feb 3, 2026
+3dSEC Form 4

Evidence

15
HW
Hall Jesse WayneChief Medical Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
98.1K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
336.3K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
96.1K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
HW
Hall Jesse WayneChief Medical Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
343.3K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
MR
McPherson Danny REVP - Technology & CSO
VRSNVERISIGN INC/CA
Tax withholding
F$388K
1,601 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

15
HL
Hess Janice L.Director
ESEESCO TECHNOLOGIES INC
Option exercise
M$322K
1,349 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

15
AE
Andrews Charles Elliott Jr.Chief Accounting Officer
CGCarlyle Group Inc.
Tax withholding
F$352K
6,354 sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

15
MJ
McKim Scott JosephEVP, Chief Financial Officer
BAFNBayFirst Financial Corp.
Tax withholding
F$592
89 sh
Feb 3, 2026Feb 6, 2026
traded Feb 3, 2026
+3dSEC Form 4

Evidence

15
BK
Balthaser KevinChief Financial Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
346.8K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

13
LC
Lee CindyChief Financial Officer
VIRTVirtu Financial, Inc.
Tax withholding
F—
2,772 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Option exercise
M$0.52
5,238 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Option exercise
M$1.61
16.1K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
OP
O'Meara Brien P.Vice President & Controller
PHMPULTEGROUP INC/MI/
Grant or award
A—
1,010 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
HP
Hill Jesse P.Chief Financial Officer
EXPIAGNT, Inc.
Tax withholding
F$5,370
637 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

13
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Option exercise
M$6.17
6,172 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
AP
Antony PrabhuDirector, Chief Financial Officer, 10% Owner
APACStoneBridge Acquisition II Corp
Grant or award
A—
100.0K sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

13
PL
Pareja LeonardoCEO of eXp Realty
EXPIAGNT, Inc.
Tax withholding
F$20K
2,283 sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence